Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Schedule of Share-based Compensation, Stock Options, Activity (Details)

v3.21.1
Stockholders' Equity - Schedule of Share-based Compensation, Stock Options, Activity (Details)
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Equity [Abstract]  
Shares, Beginning balance | shares 80,000
Shares, Granted | shares
Shares, Ending balance | shares 80,000
Shares, Exercisable, Ending balance | shares 80,000
Weighted Average Exercise Price, Beginning balance | $ / shares $ 7.01
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Exercise Price, Ending balance | $ / shares 7.01
Weighted Average Exercise Price, Exercisable, Ending balance | $ / shares $ 7.01
Remaining Contractual Life in Years, Beginning balance 3 years 2 months 12 days
Remaining Contractual Life in Years, Granted 0 years
Remaining Contractual Life in Years, Ending balance 2 years 10 months 25 days
Remaining Contractual Life in Years, Exercisable, Ending balance 2 years 10 months 25 days
Aggregate Intrinsic Value, Beginning balance | $
Aggregate Intrinsic Value, Granted | $
Aggregate Intrinsic Value, Ending balance | $
Aggregate Intrinsic Value, Exercisable, Ending balance | $